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less reduced. The following observations support the notion that DNA synthesis is blocked via inhibition of protein synthesis: (i) DNA synthesis in a cell-free system is not reduced by the drug; (ii) in cell culture protein synthesis is inhibited more rapidly and at lower concentrations than DNA synthesis; (iii) inhibitors of protein synthesis such as cycloheximide or puromycin are similar to betainyl-anguidine in their action on lymphocytes whereas specific inhibitors of DNA synthesis such as cytosine arabinoside or hydroxyurea only partially reduce protein synthesis in lymphocytes.
The sesquiterpene ovalicin at a concentration of mol/l acts as a very potent inhibitor of DNA synthesis in proliferating lymphocytes and in lymphoma cells. RNA and prorein synthesis are only weakly affected. The following observations support the conclusion that DNA synthesis is blodted only indirectly: (i) DNA synthesis in a cell-free system is not reduced by ovalicin; (ii) a cell-free system for DNA synthesis prepared from ovalicin-treated lymphocytes shows an impaired synthetic activity; (iii) in cell culture the action of ovalicin is not immediate and requires a 8-15 hour period of incubation.
Introduction
Fungi produce a large number of chemical compounds which are highly tcxic either for bacteria or for animals and plants. They are toxic because'they inhibit biochemical reactions essential for sustaining life. Their unusual specificity for eitlier animals and plants or bacteria is based on fundamental differences existing between molecular constituents of the prokaryotic and eukaryotic cell. If the receptor for the target of such a toxic compound occurs only in a eukaryotic cell exclusively this type of cell will be affected. The specificity of action is particularly pronounced if such a compound possesses a very high affinity for its target. Then very small concentrations are sufficient for the inhibitory action to be observed.
If higher concentrations (1Oa6 -10-3 mol/l) are required the high specificity of action may be lost because weak forces such as hydrophobic interactions may provoke unspecific binding of these compounds also to other cellular constituents with concomitant impairment of their biological functions. Therefore compounds which elicit biological effects at very low concentration command higher interest.
In recent years the effort to suppress the uncontrolled growth of tumor cells and other rapidly proliferating cells such as committed lymphocytes has stimulated a general interest in compounds which act cytostatic for eukaryotic cells.
In this report the mode of action of two different compounds will be discussed which exhibit a high cytostatic activity at very low concentration and act exclusively against eukaryotic cells. Chemically both compounds are distantly related since they possess the basic structure of a sesquiterpene.
I. Anguidine and related compounds
Anguidine is produced by various species of Fwsaria and shows mycotoxic At a similarly low concentration the propagation of theDNA containingvaccinia virus and its cyptopathogenic effect is suppressed [2] . With respect to the molecular target of anguidine it has been observed previously that protein synthesis in a cell culture is inhibited at a concentration of 3 X lo-' moll1 in eukaryotic cells such as rabbit reticulocytes or mouse mastocytoma cells. At the same concentration, however, DNA synthesis is equally blocked [2] . Synthesis of proteins and of DNA is achieved by biochemically very different procesws. Therefore the question arises if anguidine acts on such unlike biosynthetic pathways by two different independent modes of action. This ist not a far-fetched question. For example, it has been observed that the antibiotic rifampicin specifically blocks RNA synthesis in bacteria' [3] . On the other hand it inhibits the multiplication of vaccinia virus in cell cultures by a completely different mechanism [4] . The simultaneous inhibition of two different biochemical reactions, however, may also be explained without the assumption of two different modes of action if both reactions are tightly coupled in vivo.
In view of the observed possibly immunosuppressive activity [2] we have studied the molecular mode of action of anguidine in spleen lymphocytes from mice. In the absence of an antigenic or mitogenic stimulus lymphocytes are metabolically very inactive. Lymphocytes may be induced to proliferate by mitogens such as concanavalin A as is indicated by a strongly increased synthesis of RNA and proteins followed by a rapid synthesis of DNA after 25 h of incubation. In most of our experiments we have used the chemically modified derivative betainyl-anguidine which exhibits the same biological effects as anguidine but is much better soluble in water. If betainyl-anguidine is added simultaneously with mitogen and radioactively labelled leucine to lymphocytes in cell culture the incorporation of the radioactively labelled amino acid into proteins, determined after a 20 h incubation period, is reduced by more than the half in the presence of only 1 ~' 1 0 -8 mol/l inhibitor. Table 11 Influence of the cell cycle on the inhibitory action of verrucarin A.
The experiments were performed essentially as described in The same effect is observed with verrucarin A, a compound closely related to anguidine (table I) . Cellular protein synthesis is blocked rather rapidly. Incubation for only 3 h with 2 X moll1 verrucarin A is sufficient for avery strong inhibitory effect to be observed. .This is observed no matter whether toxin is added 7,15 on 39 hours after the mitogen (table 11) . To determine whether the synthesis of all cellular proteins is reduced to the same extent the following experiment was performed: 2 X moll1 inhibitor was added to stimulated lymphocytes which was followed by radioactively labelled methionine one hour later. After two more hours the cellular proteins were separated by polyacrylamide gel electrophoresis in presence of dodecylsulfate. Except for a single protein zone migrating with the relative electrophoretic mobility of 0.52 the synthesis of all other radioactively labelled proteins is uniformly reduced (Fig 1) . This is also true for the biosynthesis of histones as will be discussed Table III Inhibition of D N A synthesis in lymphocytes by betainyl-angr!idine, verrucarin A or ovalicin studied in cell culture and in a cell-free system. 100 p g concanavalin A, 0.5 pmol mercaptoethanol and betainyl-anguidine were added to 5 X lo7 lymphocytes in medium (see table I) (total volume 45 ml). After 38 h incubation at 37O C 0.9 ml aliquots of the cell suspension were transferred to test tubes containing 1 p C i (SH)thymidine (specific radioactivity 6.7 Cilmmol). Incorporation of radioactive label into acid insoluble material was determined after 8 h incubation a t 37O C. Control without betainyl-anguidine: 26817?1351 counts X min-I. The experiments with verrucarin A in cell culture were performed essentially as described in table I except that (SH)leucine was omitted. After 36 h incubation 0.1 ml medium containing 1 p C i ($H) thymidine (specific radioactivity 2 Cilmmol) and 10 nmol m e r~a~t b e t h a n o l was added. 18 h later incubation was terminated. Control wihout verrucarin A: 9016f 1784 counts X min-'. Experiments with ovalicin in cell culture: 1 pg concanavalin A and inhibitor was added to 10" lymphocytes preincubated for 12 h. After 38 h 1 p C i (%H)thymidine (specific radioactivity 6.7 Ci/mmol) was added and incubation continued for 3 h. Control without ovalicin: 61843k2313 counts X min-1. Synthesis of D N A in a cell-free system was measured essentially as described [7] . Nuclei were from lymphocytes stimulated for 46 h with concanavalin A in presence of 10 pM mercaptoethanol in the experiment with betainyl-anguidine (as in table I)., In the experiment with ovalicin mercaptoethanol was left out. Incubation of the cell-free system was 45 min a t 37O C. Control 
in cell culture in a cell-free system betainyl-anguidine
inhibitor of the synthesis of proteins as well as of D N A in lymphocytes. This fact has to be taken into consideration when discussing the molecular mode of action of this drug. In the case of verrucarin A DNA synthesis is even more sensitive than protein synthesis. Consequently we have to investigate the question if anguidine derivatives are double-headed inhibitors or if they block a process common to both protein and DNA synthesis. Such a process would be the production of energy in the form of ATP required for both biosynthetic reactions. However this is not the case as is shown by the following argument. Biosynthesis of RNA also requires energy in the form of ATP. However, RNA synthesis in lymphocytes is much less reduced by a concentration of the inhibitor which inhibits protein synthesis distinctly within 3 h. Even 100 fold higher concentrations of the drug reduce RNA synthesis by only 50010 (table IV) . Such a relatively weak effect on RNA synthesis has been previously observed in mouse mastocytoma cells [2] . Of course, there are many other biochemical pathways which precede both DNA and protein synthesis. Any of them could be the target of anguidine. Instead of discussing them separately we would like to mention several arguments which support the notion that anguidine and its derivatives. block DNA synthesis via the inhibition of protein synthesis.
.
(i) DNA synthesis in a cell-free system ist not inhibited by derivatives of anguidine. This process can be studied with nuclei obtained from stimulated lymphocytes [7] . During incubation of this system the activated precursors of DNA, the four deoxynucleoside Table IV Comparison of inhibitory action. o f betainyl-anguidine on RNA-and protein synthesis.
Inhibition of protein synthesis (3 h incubation): similar t o experiments described in Fig 1 except that after 40 h incubation 0.9 ml aliquots of the cell suspension was added to 0.1 ml Hank's solution containing inhibitor. After 1 h (aH)leucine was added and incorporation determined after another 2 h a t 37O C (control without drug: 16229f 3010 counts X mid1); 20 h incubation: essentially as described in table I (control without drug 4731k149 counts X min-1). Inhibition of RNA synthesis: 3 h incubation with drug: drug was added to 108 lymphocytes (table I), 18 h after concanavalin A. 2 hours later 50 nCi (14C)uridine (specific radioactivity 415 (Cilrnol) was added and incorporation into acid insoluble material determined after 1 h (control without drug 6 9 3 k 2 1 counts X min-'). 12 h incubation with drug: concanavalin A, ('4C)uridine and drug were added together to the lymphocytes. Incorporation was determined after 12 h incubation (table 111) .
(ii) In a cell, culture protein synthesis is inhibited more rapidly and a t lower concentration of the drug than DNA synthesis. Comparing the inhibitory effects of betainyl-anguidine observed after a long or a short incubation period it is immediately obvious that the inhibition of protein synthesis decreases much less than that of D N A synthesis upon shortening the incubation time. The concentration of the inhibitor has to be increased by a factor of ten to inhibit D N A synthesis to the same extent as protein synthesis during a short exposure to the drug (table V) .
(iii) Specific inhibitors of protein synthesis such as puromycin or cycloheximide inhibit D N A synthesis in lymphocytes similarly to the derivatives of anguidine. This conclusion is derived from the observation that puromycin or cycloheximide inhibit DNA synthesis in stimulated lymphocytes a t the same concentration as protein synthesis. Similar to betainyl-anguidine the effect of cycloheximide on D N A synthesis increases with the length of the exposure time. Smaller concentrations of the inhibitor are sufficient a t a long incubation time (table VI) .
All these observations are consistent with the hypothesis that protein biosynthesis is the primary target of anguidine and its derivatives. Subsequently D N A synthesis ceases. This effect is due to the tight coupling of DNA synthesis to protein synthesis in eukaryotic cells [8] which has been demonstrated with a large number of inhibitors of protein synthesis and by use of amino acid analogues in many different types of cells The effect of puromycin on protein synthesis was measured under conditions similar to those described in table I except that puromycin was added 39 h after concanavalin A. 1 h later the cells were isolated by centrifugation and resuspended in niedium containing, in addition to mitogen, mercaptoethanol and puromycin, 5 p C i (3H)leucine (specific radioactivity 50 Cilmol). Incorporation was determined after 1 h. Control without puromycin: 4800 counts X min-I. For measuring DNA-synthesis the isolated cells were resuspended in medium as above except that ('H)leucine was replaced by 1 p C i (3H)thymidine. Incorporation was determined after 1 h. Control without puromycin: 6800 count X min". Experiments with a 6 h incubation of drug: similar to those described in table 111 with betainyl-anguidine except that betainyl-anguidine or cycloheximide were added 38 h after concanavalin A. 4 h later 1 pCi (3H)thymidine or 5 p C i (3H)leucine were added and incorporation determined after 2 h. 'Controls without drug: incorporation of (3H)leucine 15850 counts X mid1; incorporation of (3H)thymidine 20705 counts X min". Experiments with cycloheximide or betainyl-anguidine (incubation with drug for 2 or 12 h resp.): similar to table I11 except that drug was added either 29 or 39 h after concanavalin A. 1 ~C i (~H ) t h y r n i d i n e was added 40 h after mitogen and the iilcubation terminated after 1 h. If protein synthesis in vivo is the primary target of anguidine one would expect that this drug is also a very potent inhibitor of protein synthesis in a cell-free ribosomal system. Indeed, it has been demonstrated previously by many investigators that this classs of compounds inhibits initiation as well as elongation of protein synthesis on eukaryotic ribosomes in a cell-free Experiments were performed similar to Fig. 1 except that 20 p C i ("C)leucine (specific radioactivity 309 Cilmol) and 4.5X10" M cytosine arabinoside were added. After incubation nuclei were prepared as described [7] and dissolved in -dodecylsulfate as in Fig. 1 . TO resolve the histones the gel system described [44] was used. Nuclear proteins [7] from 2x10' lymphocytes were applied to the gel.
Table VII
Influence of inhibitors of D N A synthesis on protein synthesis in lymphocytes.
Experiments were performed similarly to those described in table 111 except that the drug in 0.1 ml medium was added t o 0.9 ml aliquots of stimulated lymphocytes 39 hours after mitogen. One hour later (sH)thymidine o r (3H)leucine were added and incorporation into acid insoluble material measured after another 2 hours of incubation; controls without drug for DNA syn- Experiments in cell culture: Essentially as described in table IV except that verrucarin A or betainyl-anguidine were added 39.5 h after concanavalin A and (JH)leucine 30 min later.
Incubation was terminated 1 h later. Experiments with cycloheximide were carried out similarly t o the experiments in cell culture with betainyl-anguidine described in table I11 except that the drug was added 3 8 h after concanavalin A. 2 h later (sH)leucine was added and the incubation continued for 2 more hours. In vitro experiments: essentially as described [40] with rat liver supernatant [41] . Ribosomes were prepared from lymphocytes stimulated for 42 h with concanavalin A (table 111) . Experiments with added mRNA: 50 ,ug poly rU and 1 pCi (sH)phenylalanin (specific radioactivity 9 Cilmmol); time of incubation 40 min except for cycloheximide (20 min); control without drug: about 4100 counts X mid' in both experiments. In the experiments using endogenous mRNA 1 p C i (%H)leucine was used as radioactive precursor; time of incubation: 20 min. Control without drug: 5195 counts X min''. are required for inhibition under these conditions. We have confirmed these observation for the inhibition of protein synthesis in a cell-free system with ribosomes from stimulated lymphocytes using either polyribouridylic acid or endogeneous RNA as messenger. To obtain 50°/o inhibition 2 X mol/l of the toxin is required (table VIII) . Obviously in this system protein synthesis is also much less sensitive to betainyl-anguidine than in cell culture. This unexpected discrepancy between the effect in cell culture and in a cell-free system has been observed with other inhibitors of protein synthesis such as cycloheximide [20, [26] [27] [28] and emetine [12, 281 in various eukaryotic cells and cellfree systems. We have confirmed the observation with cycloheximide in stimulated lymphocytes (table VIII) . It may be explained by assuming the presence or absence of a soluble protein factor which determines the sensitivity to the inhibitors. O n the basis of this assumption the concentration of such a soluble factor would control the inhibitory activity of the drugs. Indeed, su& a soluble protein has been isolated from the supernatant of a yeast lysate which renders sensitivity towards cycloheximide to the cell-free system from yeast [29] .
II. Ovalicin
Ovalicin has been isolated from the culture medium of the ascomycetePseud- [30] . Its immunosuppressive activity in vivo deserves particular attention: the number of antibody producing cells in the spleen of mice immunized with sheep red blood cells decreases to less than one per cent if 600 mg ovalicin per kg mouse is injected one day after immunisation. With later injection the inhibitory effect declines rapidly. Similarly the graft versus host reaction is distinctly delayed by ovalicin. The drug reduces the number of mitoses in spleen cells of immunised mice whereas the mitotic index in the jejunum is unchanged [31, 321. These observations suggested a study of the action of ovalicin on cells of the lymphatic system. Following our proposal SCHIMPL and WECKER have investigated the effect of the drug on the induction of antibody production in cultures of mouse spleen cells [33] . Surprisingly the activity of ovalicin in this system turned out to be much higher than in the animal. Even a t a concentration of 4 X 10-9 mol/l a distinct inhibition was observed [34] . One reason for the apparently lower activity in the animal may be the much higher metabolic turnover rate of the drug.
We decided to analyse the mode of action of ovalicin by measuring a more IX) .
All these observations demonstrate that ovalicin is one of the most potent low-molecular inhibitors of proliferation of lymphocytes. were added and the incubation continued for 6 h. Lymphoblastoma~cells: Exponentially growing cells were cultured a t 3 7 ' C in Dulbecco's modified Eagle's medium (without nonessential amino acids) containing 10D/o fetal calf serum (total volume 15 ml) with or without drug. After 48 h 0.9 ml aliquots were transferred to test tubes, 1 p C i (=H)thymidine (specific radioactivity 0.5 Cilmmol) in 0.1 ml was added and the incubation continued for 1 h.
Spleen cells (athymic nulnu mouse): lo6 cells were incubated in the presence of 2 pg lipopolysaccharide and ovalicin for 36 h (total volume 1 ml). Subsequently 1 ;uCi (3H)thymidine was added and the incubation continued for 24 h. Human peripheral blood lymphocytes: lymphocytes from fresh human blood (42) were treated as described under spleen cells except that 5 cells [35] . In each case the proliferation induced by these type-specific mitogens is inhibited by very small concentrations of ovalicin (table IX) . This is also true for the mitogen induced proliferation of human peripheral lymphocytes (table IX) . Similarly, thymidine incorporation in transformed lymphocytes such as monoclonal S 49.1 mouse lymphoma cells [36] is strongly reduced after 48 h incubation with the toxin (table IX) . This observation demonstrates the direct action of ovalicin on lymphocytes. Its action is not mediated by cell-cell interaction, for example via macrophages. The inhibitory action of ovalicin on cells different from those of the lymphatic system has also been studied. Thymidine incorporation in 3T6 mouse fibroblasts or HeLa cells is distinctly less inhibited by ovalicin. Incubation with 2 X lo-' mol/l drug for two days results in only 30-40°/o inhibition whereas at this concentration inhibition in S 49.1 lymphoma cells is 80°/o a t this concentration. However, the smaller inhibitory effect on 3T6 or HeLa cells is already detectable a t the low drug concentration of 2 X mol/l (data not shown). These observations suggest that lymphocytes are moresusceptible to the action of ovalicin than other cells, in agreement with observations on the effects of the drug on the various animal tissues [31] .
In the -experiments reported so far incorporation of the nucleoside thymidine into DNA was used as analytical tool to demonstrate the activity of ovalicin. If DNA synthesis is directly affected the drug should be able to block the incorporation of deoxyribonucleoside triphosphates into DNA in a cell free system from lymphocytes [7] . However, even a t concentration of 3 X moll1 ovalicin does not act inhibitory in this system (table 111) . Obviously the polycondensation of precursors to DNA is not the target of the drug. O n the other hand DNA synthesis is clearly element of the DNA synthesizing machinery.
If this notion is correct it is be expected that the time of addition of the inhibitor to the cell culture should clearly influence the extent of inhibition. Indeed, this notion has been confirmed. If ovalicin is added to a spleen cell culture at various times after mitogenic stimulation maximal inhibition is ohserved only when the drug is added until the 6th to the 8th hour after mitogen. If added 16-20 h after mitogen no effect is.measured on the DNA synthesis measured 14 h later (Fig. 3) . Obviously the early phase of lymphocyte stimulation is particularly sensitive to the inhibitor.
O n the other hand, characteristic reactions occurring immediately after reduced in a cell-free system prepared addition of the mitogen are not a t all from lymphocytes which had been reduced by the drug. This conclusion preincubated with ovalicin compared may be derived from the observation with the activity of a system from that ovalicin added 6 h after the mitountreated cells (table X) . This observa-gen shows its full inhibitory activity tion supports the notion that ovalicin (Fig. 3) . The same conclusion is derived inhibits the formation of an essential from the investigation of the lipid Table X Influence o f ovalicin on the incorporation of (3H)dTTP into DNA of nuclei of lymphocytes. The experiment was performed as described in table I11 except that nuclei were prepared from lymphocytes (2X 10' cells/ml) stimulated for 46 h with 1 ,ug/ml concanavalin A in the absence of mercaptoethanol; concentration of ovalicin: 7 X 10-7 molll. turnover which, in lymphocyte membranes, is significantly increased very soon after addition of mitogen [37] . The lipid turnover is increased also in presence of ovalicin (table XI) .
These observations may lead to the conclusion that ovalicin acts on stimulated lymphocytes only during a very short phase of the cell cycle (6-12 h after addition of mitogen). However, this conclusion could not be confirmed. Rather a 14-16 h incubation period of the drug is required for maximum inhibition of stimulated spleen lymphocytes from mouse as is shown by the following experiments: in the first experiment the drug was added to the cell culture various times after the mitogen. 20 h after addition of the mitogen the inhibitor was removed from all samples by repeated washing (Fig. 4 (0) ). The strongest inhibition of DNA synthesis was observed when ovalicin had acted on the cells for at least 16 h. In the second experiment the drug was added uniformly to all samples 6 h after mitogen. It was then removed from the samples after 2-14 h incuba-.tion (Fig. 4 (A) ). As in the previous experiment an incubation period of at However we were unable to detect any metabolic products in the medium of the cell culture after a long incubation with the drug which would inhibit stimulated lymphocytes with higher activity (data not shown).
The preceding experiments show that the cell cultures have to be incubated with ovalicin for a rather long period of time to obtain a maximal inhibitory effect. But at which time can the first effect of the drug be observed? If the rate of DNA synthesis is measured using short pulses of radioactively labklled thymidine and starting immediately after addition of mitogen, an incorporation of thymidine into DNA is observed as soon as 7-8 h after mitogen (Fig. 5) . Although exceedingly small, it is clearly higher than that observed in a cell culture not having received mitogen. If 2 X lo-' moll1 ovalicin are added together with the mitogen even this very early incorporation is distinctly inhibited (Fig. 5) . Again the effect of ovalicin is not observed immediately after addition but requires an incubation period of several hours (data not shown).
All these observations are at variance with DNA synthesis as a direct target of the drug. Therefore the action of the toxin on the biosynthesis of other macromolecules has also been investigated. Incorporation of radioactively labelled uridine into the acid insoluble material of cell lysate was used to assay for the biosynthesis of RNA. Incorporation of uridine into RNA is significant even in resting lymphocytes. It is not reduced even by 3 X mol/l ovalicin. In lymphocytes stimulated with concanavalin A RNA synthesis is only weakly inhibited after 20 h incubation with the drug (Table XII) . Obviously, RNA synthesis as followed by total incorporation of a precursor, is not the target of the drug.
Furthermore, this observation also indicates that the production of energy in lymphocytes is not the target of ovalicin because RNA synthesis is strongly dependent on this process.
In eukaryotic cells, DNA synthesis is tightly coupled to protein synthesis as has been discussed in the section on anguidine. Therefore the influence of ovalicin on protein synthesis has been investigated. The incorporation of radioactively labelled leucine into the acid insoluble material of cell lysates was used to assay for protein biosyn-.thesis. 14 h incubation with 2 X mol/l ovalicin leads to a 20010 reduction of protein synthesis whereas the small extent of DNA synthesis is already redu-incubation (h) after addition of mitogen ced by 60-70°/o at this early phase of be the consequence of the blodted biothe cell cycle (table XIII) . The inhibi-synthesis of DNA as has been discussed tion of protein synthesis is increased.to above. In this context we wish to men-400/0 when the incubation period with tion the observation that the elongation the drug is extended to40 h (table~111). process of protein biosynthesis as meaThis increased extent of inhibition may sured with ribosomes from stimulated lymphocytes in a cell-free system is not inhibited by 3 X mol/l ovalicin (table XIV) .
If the inhibition of protein biosynthesis by the toxin is the direct consequence of the inhibition of DNA synthesis the formation of the histones should be affected particularly as has been shown above for cytosine arabinoside by electrophoretic analysis (Fig. 2) . However, this is not found. I n the presence of ovalicin the formation of all proteins is uniformly reduced (data not shown).
Summarizing the numerous observations reported we have to conclude that neither DNA nor protein synthesis is a direct target of ovalicin. This notion is supported by a comparison of the ovalicin (Fig. 6) . In contrast DNA synaction of ovalicin with that of cyclo-thesis, as measured simultaneously by (Fig. 6) . addition of the mitogen to a cell culture These oberservations indicate that the the average diameter of the cells increases up to the 48th hour of incubation as measured in the microscope. If cycloheximide is added together with the mitogen the average diameter of the lymphocytes remains unchanged as in the absence of mitogen. Obviously continuous protein synthesis is required for blast cell formation. In the presence of cytosine arabinoside the average cell diameter increases up to the 24th hour almost as much as in the absence of this specific inhibitor of DNA synthesis. mechanism of action of ovalicin is very different from that of specific inhibitors of protein and DNA synthesis. Further investigations to pinpoint the target will be required. They promise to be rewarding since they will reveal the reason for the exceptionally high sensitivity of lymphocytes to the toxin as well as a key reaction crucial for lymphocyte proliferation, since otherwise 10-lo moll1 ovalicin would not be expected to act inhibitory.
During the following day no further in-~cknow~a~gemenls crease is observed. The effect of ovalicin is very different from that of the Lymphocytes were stimulated as described in table XI. Drugs were added togehter with the mitogen: 2 X 10.' M ovalicin, 1 X M cycloheximide or 1 X 10" M cytosine arabinoside, respectively. About 5X106 washed cells [in 0.25 ml) were mixed with 0.5 ml warm 0.5O/o agarose in phosphate-buffered saline,and applied to slides.The coated slides were treated with (X5O/o glutaraldehyde in phosphate-buffered saline, washed three times for 5 min in destilled water, air-dried and Giemsastained [45] . The diameter of the stained cells was estimated at a magnification of 1 :I250 in arbitrary units and the average diameter of 250 cells calculated. D N A synthesis (values in per cent are given in brackets) at 24, 36 and 48 h of incubation after addition of concanavalin A was determined by an one hour (3H)thymidine pulse (1 pCilrnl; 0.5 Ci/mmol) in 0.9 ml aliquots of the cell culture. 100°/0 of D N A synthesis at 24, 36 and 48 h respectively: 19957k84, 50285k 3286, 116805k222 counts X min-', respectively. In the presence of cycloheximide or cytosine arabinoside the incorporation of thymidine into the acid-insoluble material of the cells is neglegible.
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